Cardiac Glycoside Neriifolin Exerts Anti-cancer Activity in Prostate Cancer Cells by Attenuating DNA Damage Repair through Endoplasmic Reticulum Stress

Investigators reported that cardiac glycoside neriifolin suppressed the malignancy of cancer cells via increasing DNA damage and apoptosis through activation of endoplasmic reticulum stress in prostate cancers.